-
Electronic (PDF)
-
Site License
-
Enterprisewide
Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
GlobalData, December 2012, Pages: 107
Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Summary
Our new report, “Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Histology And Cytology market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within seven market categories – Tissue Typing Reagents, Flow Cytometers and Monoclonal Antibodies. The report also provides company shares and distribution shares data for the overall Histology And Cytology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.
Scope
- Market size data for Histology And Cytology market categories – Tissue Typing Reagents, Flow Cytometers and Monoclonal Antibodies
- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the seven market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.
- 2011 company shares and distribution shares data for the overall Histology And Cytology market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Histology And Cytology market in BRICS.
- Key players covered include Becton, Dickinson and Company, Beckman Coulter, Inc., Sysmex Corporation, F. Hoffmann-La Roche Ltd., Life Technologies Corporation, Abbott Laboratories, Danaher Corporation, Trivitron Healthcare Pvt Ltd. and Thermo Fisher Scientific Inc.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Histology And Cytology competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Histology And Cytology in BRICS
3.1 Histology And Cytology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018
3.2 Histology And Cy tology, BRICS, Company share (2010-2011)
4 Histology And Cytology In Brazil
4.1 Histology And Cytology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
4.2 Tissue Typing Reagents In Brazil
4.2.1 Tissue Typing Reagents, Brazil, Overall Revenue (2004-2018)
4.3 Monoclonal Antibodies In Brazil
4.3.1 Monoclonal Antibodies, Brazil, Overall Revenue (2004-2018)
4.4 Flow Cytometers In Brazil
4.4.1 Flow Cytometers, Brazil, Overall Revenue (2004-2018)
4.5 Histology And Cytology, Brazil, Distribution Share (2010-2011)
4.6 Histology And Cytology, Brazil, Company Share (2010-2011)
5 Histology And Cytology In Russian Federation
5.1 Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018
5.2 Tissue Typing Reagents In Russian Federation
5.2.1 Tissue Typing Reagents, Russian Federation, Overall Revenue (2004-2018)
5.3 Flow Cytometers In Russian Federation
5.3.1 Flow Cytometers, Russian Federation, Overall Revenue (2004-2018)
5.4 Monoclonal Antibodies In Russian Federation
5.4.1 Monoclonal Antibodies, Russian Federation, Overall Revenue (2004-2018)
5.5 Histology And Cytology, Russian Federation, Distribution Share (2010-2011)
5.6 Histology And Cytology, Russian Federation, Company Share (2010-2011)
6 Histology And Cytology In India
6.1 Histology And Cytology, India, Overall Revenue ($m), USD Constant, 2004-2018
6.2 Tissue Typing Reagents In India
6.2.1 Tissue Typing Reagents, India, Overall Revenue (2004-2018)
6.3 Flow Cytometers In India
6.3.1 Flow Cytometers, India, Overall Revenue (2004-2018)
6.4 Monoclonal Antibodies In India
6.4.1 Monoclonal Antibodies, India, Overall Revenue (2004-2018)
6.5 Histology And Cytology, India, Distribution Share (2010-2011)
6.6 Histology And Cytology, India, Company Share (2010-2011)
7 Histology And Cytology In China
7.1 Histology And Cytology, China, Overall Revenue ($m), USD Constant, 2004-2018
7.2 Flow Cytometers In China
7.2.1 Flow Cytometers, China, Overall Revenue (2004-2018)
7.3 Tissue Typing Reagents In China
7.3.1 Tissue Typing Reagents, China, Overall Revenue (2004-2018)
7.4 Monoclonal Antibodies In China
7.4.1 Monoclonal Antibodies, China, Overall Revenue (2004-2018)
7.5 Histology And Cytology, China, Distribution Share (2010-2011)
7.6 Histology And Cytology, China, Company Share (2010-2011)
8 Histology And Cytology In South Africa
8.1 Histology And Cytology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
8.2 Flow Cytometers In South Africa
8.2.1 Flow Cytometers, South Africa, Overall Revenue (2004-2018)
8.3 Tissue Typing Reagents In South Africa
8.3.1 Tissue Typing Reagents, South Africa, Overall Revenue (2004-2018)
8.4 Monoclonal Antibodies In South Africa
8.4.1 Monoclonal Antibodies, South Africa, Overall Revenue (2004-2018)
8.5 Histology And Cytology, South Africa, Distribution Share (2010-2011)
8.6 Histology And Cytology, South Africa, Company Share (2010-2011)
9 Overview of Key Companies in BRICS Histology And Cytology Market
9.1 Becton, Dickinson and Company
9.1.1 Company Overview
9.1.2 Share in the BRICS Histology And Cytology Market
9.2 Beckman Coulter, Inc.
9.2.1 Company Overview
9.2.2 Share in the BRICS Histology And Cytology Market
9.3 Sysmex Corporation
9.3.1 Company Overview
9.3.2 Share in the BRICS Histology And Cytology Market
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Share in the BRICS Histology And Cytology Market
9.5 Life Technologies Corporation
9.5.1 Company Overview
9.5.2 Share in the BRICS Histology And Cytology Market
9.6 Abbott Laboratories
9.6.1 Company Overview
9.6.2 Share in the BRICS Histology And Cytology Market
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Share in the BRICS Histology And Cytology Market
9.8 Trivitron Healthcare Pvt Ltd.
9.8.1 Company Overview
9.8.2 Share in the BRICS Histology And Cytology Market
9.9 Thermo Fisher Scientific Inc.
9.9.1 Company Overview
9.9.2 Share in the BRICS Histology And Cytology Market
10 Appendix
10.1 Definitions of Markets Covered in the Report
10.1.1 Histology And Cytology
10.2 Research Methodology
10.3 Secondary Research
10.4 Primary Research
10.5 Models
10.6 Forecasts
10.7 Expert Panels
10.8 Consulting
10.9 Currency Conversion
10.10 Contact Us
10.11 Disclaimer
1.1 List of Tables
Table 1: Histology And Cytology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Histology And Cytology, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 3: Histology And Cytology, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 4: Histology And Cytology, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011
Table 5: Histology And Cytology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
Table 6: Histology And Cytology, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 7: Histology And Cytology, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 8: Tissue Typing Reagents, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Table 9: Tissue Typing Reagents, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 10: Monoclonal Antibodies, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Table 11: Monoclonal Antibodies, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 12: Flow Cytometers, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Table 13: Flow Cytometers, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 14: Histology And Cytology, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Histology And Cytology, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018
Table 17: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 18: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 19: Tissue Typing Reagents, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Table 20: Tissue Typing Reagents, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 21: Flow Cytometers, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Table 22: Flow Cytometers, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 23: Monoclonal Antibodies, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Table 24: Monoclonal Antibodies, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 25: Histology And Cytology, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 26: Histology And Cytology, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 27: Histology And Cytology, India, Overall Revenue ($m), USD Constant, 2004-2018
Table 28: Histology And Cytology, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 29: Histology And Cytology, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 30: Table 31: Tissue Typing Reagents, India, Revenue ($m), USD Constant, Historic, 2004-2011
Table 32: Tissue Typing Reagents, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 33: Flow Cytometers, India, Revenue ($m), USD Constant, Historic, 2004-2011
Table 34: Flow Cytometers, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 35: Monoclonal Antibodies, India, Revenue ($m), USD Constant, Historic, 2004-2011
Table 36: Monoclonal Antibodies, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 37: Histology And Cytology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 38: Histology And Cytology, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 39: Histology And Cytology, China, Overall Revenue ($m), USD Constant, 2004-2018
Table 40: Histology And Cytology, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 41: Histology And Cytology, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 42: Flow Cytometers, China, Revenue ($m), USD Constant, Historic, 2004-2011
Table 43: Flow Cytometers, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 44: Tissue Typing Reagents, China, Revenue ($m), USD Constant, Historic, 2004-2011
Table 45: Tissue Typing Reagents, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 46: Monoclonal Antibodies, China, Revenue ($m), USD Constant, Historic, 2004-2011
Table 47: Monoclonal Antibodies, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 48: Histology And Cytology, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 49: Histology And Cytology, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Histology And Cytology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
Table 51: Histology And Cytology, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 52: Histology And Cytology, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 53: Table 54: Flow Cytometers, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Table 55: Flow Cytometers, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 56: Tissue Typing Reagents, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Table 57: Tissue Typing Reagents, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 58: Monoclonal Antibodies, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Table 59: Monoclonal Antibodies, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 60: Histology And Cytology, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 61: Histology And Cytology, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 62: Becton, Dickinson and Company, Revenue ($m), BRICS Histology And Cytology Market, 2011
Table 63: Beckman Coulter, Inc., Revenue ($m), BRICS Histology And Cytology Market, 2011
Table 64: Sysmex Corporation, Revenue ($m), BRICS Histology And Cytology Market, 2011
Table 65: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Histology And Cytology Market, 2011
Table 66: Life Technologies Corporation, Revenue ($m), BRICS Histology And Cytology Market, 2011
Table 67: Abbott Laboratories, Revenue ($m), BRICS Histology And Cytology Market, 2011
Table 68: Danaher Corporation, Revenue ($m), BRICS Histology And Cytology Market, 2011
Table 69: Trivitron Healthcare Pvt Ltd., Revenue ($m), BRICS Histology And Cytology Market, 2011
Table 70: Thermo Fisher Scientific Inc., Revenue ($m), BRICS Histology And Cytology Market, 2011
1.2 List of Figures
Figure 1: Histology And Cytology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018
Figure 2: Histology And Cytology, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 3: Histology And Cytology, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 4: Histology And Cytology, BRICS, Company share (%), 2011
Figure 5: Histology And Cytology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
Figure 6: Histology And Cytology, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: Histology And Cytology, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: Tissue Typing Reagents, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 9: Tissue Typing Reagents, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 10: Monoclonal Antibodies, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 11: Monoclonal Antibodies, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 12: Flow Cytometers, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 13: Flow Cytometers, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 14: Histology And Cytology, Brazil, Company Share (%), 2011
Figure 15: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018
Figure 16: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 17: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 18: Tissue Typing Reagents, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 19: Tissue Typing Reagents, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 20: Flow Cytometers, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 21: Flow Cytometers, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 22: Monoclonal Antibodies, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 23: Monoclonal Antibodies, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 24: Histology And Cytology, Russian Federation, Company Share (%), 2011
Figure 25: Histology And Cytology, India, Overall Revenue ($m), USD Constant, 2004-2018
Figure 26: Histology And Cytology, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 27: Histology And Cytology, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 28: Tissue Typing Reagents, India, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 29: Tissue Typing Reagents, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 30: Flow Cytometers, India, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 31: Flow Cytometers, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 32: Monoclonal Antibodies, India, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 33: Monoclonal Antibodies, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 34: Histology And Cytology, India, Company Share (%), 2011
Figure 35: Histology And Cytology, China, Overall Revenue ($m), USD Constant, 2004-2018
Figure 36: Histology And Cytology, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 37: Histology And Cytology, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 38: Flow Cytometers, China, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 39: Flow Cytometers, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 40: Tissue Typing Reagents, China, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 41: Tissue Typing Reagents, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 42: Monoclonal Antibodies, China, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 43: Monoclonal Antibodies, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 44: Histology And Cytology, China, Company Share (%), 2011
Figure 45: Histology And Cytology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
Figure 46: Histology And Cytology, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 47: Histology And Cytology, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 48: Flow Cytometers, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 49: Flow Cytometers, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 50: Tissue Typing Reagents, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 51: Tissue Typing Reagents, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 52: Monoclonal Antibodies, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 53: Monoclonal Antibodies, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 54: Histology And Cytology, South Africa, Company Share (%), 2011
Figure 55: Becton, Dickinson and Company, Company Share (%), BRICS Histology And Cytology Market, 2011
Figure 56: Beckman Coulter, Inc., Company Share (%), BRICS Histology And Cytology Market, 2011
Figure 57: Sysmex Corporation, Company Share (%), BRICS Histology And Cytology Market, 2011
Figure 58: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Histology And Cytology Market, 2011
Figure 59: Life Technologies Corporation, Company Share (%), BRICS Histology And Cytology Market, 2011
Figure 60: Abbott Laboratories, Company Share (%), BRICS Histology And Cytology Market, 2011
Figure 61: Danaher Corporation, Company Share (%), BRICS Histology And Cytology Market, 2011
Becton, Dickinson and Company
Beckman Coulter, Inc.
Sysmex Corporation
F. Hoffmann-La Roche Ltd.
Life Technologies Corporation
Abbott Laboratories
Danaher Corporation
Trivitron Healthcare Pvt Ltd.
Thermo Fisher Scientific Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
